[Cyclosporin A therapy in pyoderma gangraenosum].
A 33-year-old woman with pyoderma gangrenosum was treated with cyclosporine A. Cyclosporine A is a valuable drug for the treatment of recalcitrant pyoderma gangrenosum. Its mechanism of action is discussed. The numerous side-effects require close monitoring of cyclosporine A blood levels and several other parameters.
Zumdick
M
M
Hautklinik, Heinrich-Heine-Universität Düsseldorf.
Schuppe
H C
HC
Goerz
G
G
D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007868:Leg Dermatoses / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008111:Liver Function Tests; D008657:Metabolic Clearance Rate; D017511:Pyoderma Gangrenosum / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology
D016572:Cyclosporine
Cyclosporin-A-Therapie bei Pyoderma gangraenosum.